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ABSTRACT 
Blood safety is a major issue of global concern in transfusion medicine especially in developing countries, where 
national blood transfusion policies and services as well as financial resources are lacking or inadequate. 
Transfusion-transmitted malaria is a potential health hazard but is often neglected in many malarious areas. 
Malaria infection among blood donors in Onitsha urban, Southeast Nigeria was studied between August and 
October 2008. Venous blood of donors was screened for malaria parasites using Giemsa-stained thick and thin 
blood films. The ABO and Rhesus phenotypes were classified using a haemaglutination standard test and 
demographic data of donors documented. Of the 410 blood donors analysed, 304 (74.1%) were infected. 
Plasmodium falciparium was identified in all positive cases and mixed infection with P. malariae was seen in 
5(1.6%) cases. Infection significantly varied with age and not with sex and occupation (p<0.05).  People with 
blood group O+ showed significantly higher rate of infection (p<0.05). Since there is scarcity of voluntary donors 
in Nigeria, donor deferral done in non-malarial endemic regions cannot be practiced in Nigeria. The high 
prevalence of asymptomatic malaria in this area, suggests the need for careful screening of blood samples for 
malaria parasites. Positive samples should be indicated on the blood packs and transfusion of malaria positive 
blood requires the administration of curative dose of antimalarials to the patient. Commercial donors should be 
freely given mosquito treated bed nets and be encouraged to sleep under them. 
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INTRODUCTION  
Malaria is one of the world’s deadliest diseases that 
are placing more than half of the world’s population 
at risk. In the vast majority of tropical and sub-
tropical regions of the world, malaria remains the 
most complex and overwhelming health problem 
facing humanity, with 300 to 500 million cases and 
2 to 3 million deaths per year (World Health 
Organisation, 2010). About 90% of all malaria 
deaths in the world today occur in Africa south of 
the Sahara. The majority of infections in the region 
are caused by Plasmodium falciparium, the most 
dangerous of the five human malaria parasites 
(Bronner et al., 2009; van Hellemond et al., 2009; 
Daneshvar et al., 2010). The most effective malaria 
vector - the mosquito Anopheles gambiae and the 
most difficult to control is also widespread in this 
region (World Health Organisation, 2003). This has 
serious implication as it leads to loss of man hours 
and decrease in national productivity. 
 
Transfusion therapy is a form of treatment based on 
the use of blood and its product on human. 
Although this therapy helps to save lives, blood can 
nonetheless be a vehicle for transmission of 
infections including parasitic diseases. Among them 
is a malaria fever, caused by Plasmodium species 
(Okocha et al., 2005). The malaria parasite is 
intraerythrocytic, hence can be transmitted by 
transfusion of any blood component containing 
infected cells. Transfusion Transmitted Malaria 
(TTM), compared to natural infection often has a 
short incubation period because there is no pre-
erythrocytic development and depends on the 
species of parasite introduced which varies from 10 
days in P. falciparium to 40 days or longer in P.  
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malariae (Bruce-Chwatt, 1974; Mohareb, 1995). 
Malaria parasites of all species can remain viable in 
stored blood for at least one week and can even 
survive longer in frozen blood (Kark, 1982). For 
instance, P. falciparium has been transmitted 
through blood stored for 19 days (Desilva et al., 
1988).  
 
The World Health Organisation and the 
International Society of Blood Transfusion 
encourage voluntary donation of blood in all 
circumstances. Unfortunately, there is scarcity of 
voluntary donors in Nigeria while commercial 
donors abound (WHO, 1984). Such commercial 
donors are poor low income groups and whose 
motive for blood donation is purely financial. Under 
the current policy in the United States of America, 
individuals who have had malaria are deferred for 
three years after becoming asymptomatic. 
Travelers from non – endemic countries with no 
previous history of malaria are deferred for one 
year period, after departing from endemic areas. 
Prior residents of malaria endemic countries are 
deferred for a three-year period after each 
departure from an endemic country (FDA, 2006). In 
Nigeria, screening for malaria parasite is neither 
routinely done in blood banks, nor stipulated in the 
current National Blood Transfusion Guidelines. This 
is because transmission of malaria through blood 
transfusion is generally not regarded as a serious 
problem in adult and adolescent whose level of 
immunity is thought to be sufficiently effective in 
combating post transfusion malaria in an endemic 
area like Nigeria (Federal Ministry of Health 
Nigeria, 1991; Attah, 2000]. In Nigeria , as in other 
tropical developing countries, the high level of 
occurrence of blood-demanding health conditions 
due to increase in road traffic accidents, pregnancy- 
related haemorrhage, armed robbery attacks, and 
violent events, amplify the possibility of the 
transmission of blood-borne diseases (Uneke et al., 
2006).  
 
The long standing concern about transfusion-
transmitted hepatitis and Human 
Immunodeficiency Virus (HIV) infection has 
overshadowed the fact that other diseases, 
particularly malaria could be spread by transfusion 
of blood components (Kaur and Basu, 2005). Blood 
safety, therefore, remains an issue of major concern 
in transfusion medicine in developing countries, 
where national blood transfusion policies and 
services, appropriate infrastructure, trained 
personnel and financial resources are lacking or 
inadequate. It is against this background that this 
study aims to determine the prevalence of malaria 
parasitaemia among blood donors, in Onitsha 
urban, Anambra State of Eastern Nigeria, a 
holoendemic area. This is with the view of 
determining the possible risk of transmission of 
malaria parasites to recipients of donated bloods, 
and to providing scientific evidence required for the 
formulation of effective blood-donation policy in 
resource-constrained settings in the tropics.    
   
MATERIALS AND METHODS 
Study Area 
The study was carried out in three government 
approved medical laboratories with blood banks in 
Onitsha urban. Onitsha is located in Onitsha South 
Local Government Area, within latitude 60 05/ N and 
longitude 70 05/ E. The climate is tropical with an 
average yearly rainfall of 2000mm, a mean air 
temperature of 27.60C and an annual relative 
humidity of 75%. Onitsha is located along the banks 
of River Niger, from which the name Nigeria was 
coined and it is a vast city with the largest market 
(Onitsha Main Market) in West Africa. Majority of 
the inhabitants of the city are traders. Some parts of 
the city like Okpoko, can be described as slums. 
Overcrowding and unsanitary conditions in some 
parts of Onitsha urban have led to all season 
breeding of Anopheline mosquitoes like Anopheles 
gambiae, A. funestus, A. nili and A. pharoensis.  
 
Consent   
Informed consent was obtained from the directors 
of the medical laboratories where the study was 
conducted. All donors presenting at the laboratories 
for blood donation were verbally notified about the 
study prior to sample collection and they readily 
gave their consent. The blood samples used for this 
study were taken from the donated blood. 
 
Study Population, Techniques and Analysis 
The study was carried out between  August and 
October, 2008. The three prominent medical 
laboratories chosen for the study were Gem Medical 
Laboratory, SDO Medical Laboratory and 
Resurrection Medical Laboratory. The choice of the 
three laboratories was because most blood donors 
patronise them and hospitals refer patients to buy 
blood from these laboratories. The subjects were 
apparently healthy individuals who did not show 
any common signs of malaria, such as fever either in 
the cold or sweating stage, headache and physically 
detected anaemia, shivering, pain at body joints, 
weakness and vomiting. The donors were also
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screened for HIV-1 and Hepatitis B virus and 
confirmed negative for these infection. Thus, every 
person who came to donate blood and was 
confirmed fit was involved in the study. The blood 
samples were collected daily throughout the study 
period. The blood donors included, 364 commercial 
(were paid by the medical laboratories for donating 
blood), 29 relation (were those that donated blood 
for sick people who are related to them) and 17 
volunteer donors (donated blood voluntarily). Both 
relation and volunteer donors do not receive any 
form of financial reward. 
 
Venous blood containing ethylenediamine tetra 
acetic acid (EDTA) routinely collected for 
haematological analysis was used. To ensure 
anonymity of the donors, numbers, not names were 
used. Giemsa-stained thick and thin blood films 
were performed within an hour of blood collection, 
to identify individuals infected with the malaria 
parasite as previously described by (Cheesbrough, 
1998). Parasite count was determined using the 
plus system (WHO, 2002). Parasitological analysis 
was confirmed by independent experienced 
microscopists who were unaware of each result 
according to the World Health Organisation 
recommended procedures. The ABO/Rhesus 
phenotypes were performed for all subjects using 
the slide method (Ibhanesebho et al., 1996), with 
commercially available reagents (Murex. Inc. 
Dartford. UK).  
 
Data on age, gender, haemoglobin (Hb) level and 
occupation of each donor were also documented 
during blood collection. Minitab for windows 11 
was used for data storage and statistical analyses. 
Proportions and categorical data were compared by 
the Chi-square test. The adopted significance level 
for statistical inference was p< 0.05.  
 
RESULTS 
The mean age of the donors was 31.45 ± 8.65years, 
while their mean Hb was 14.4 ± 5.81g/dl. Majority 
of the donors 364(88.8%) were males while 
46(11.2%) were females. Among these were 
364(88.8%) commercial, 17(4.1%) volunteer and 
29(7.1%) relation blood donors. Of the 410 blood 
donors, 304(74.1%) were infected with malaria 
parasite. Among the infected individuals, 176 
(57.9%) had 1-10 parasites per 100 thick film fields 
(‘+’ or 1-40 parasites per mm3), while 128 (42.1%) 
had 11-100 parasites per 100 thick film fields (‘++’ 
or 41-400 parasites per mm3). Plasmodium 
falciparium was identified in all the infected cases, 
but mixed infections with P. malariae were also 
identified in 5(1.6%) of cases. Infection rates of 
77.5%, 48.3% and 47.1% were recorded among 
commercial, relation and volunteer blood donors 
respectively. This difference was however not 
statistically significance (χ2cal = 3.27, χ2tab = 5.99, df 
=2, p> 0.05). Among the 364 male donors, 274 
(75.3%) were infected while among the 46 female 
donors 30(65.2%) were infected. 














































20-24 27 19(70.4) 2 1(50.0) 29 20(69.0) 
25-29 139 117(84.2) 25 18(72.0) 164 135(82.3) 
30-34 103 81(78.6) 12 8(66.7) 115 89(77.4) 
35-39 44 33(72.7) 4 2(50.0) 48 35(72.9) 
40-44 34 22(64.7) 3 1(33.3) 37 23(62.2) 
45-49 13 2(15.4) -  - 13 2(15.4) 
50-59 4 0(0) -  - 4 0(0.0) 
Total 364             274(75.3) 46             30(65.2) 410  304(74.1) 
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The age group 25-29 years recorded the highest 
infection rate of 82.3% after which the infection 
decreased with age. No female donated blood in the 
age group 45-49 and 50-54years while no infection 
was observed in the age group 50- 54years for 
males (Table 1). A difference in age (χ2cal = 44.27, 
χ2tab = 12.59, df =6, p< 0.05) but not with sex (χ2cal = 
2.09, χ2tab = 3.84, df =1, p>0.05) was shown 
statistically.  
 
Table 2: Malaria Infection in Relation to Blood 
Groups and Rhesus Factors among Blood 
Donors in Onitsha, Southeastern, Nigeria 
 










O+ 226 213 80.1 
O- 46 28 60.9 
A+ 52 33 63.5 
B+ 43 28 65.1 
B- 3 2 66.7 
 
Table 3: Malaria Infection in Relation to 










117 90 76.9 
Traders 63 50 79.4 
Students 27 19 70.4 
Bus 
conductors 
34 25 73.5 
Medical Lab. 
Scientists 
11 8 72.7 
Medical 
doctors 




25 18 72.0 
Commercial 
motor drivers 
25 17 68.0 
Apprentices 60 46 76.7 
Painters 15 10 66.7 
Mechanics 20 13 65.0 
 
Blood group O+ was the dominant blood type 
followed by A+, O-, B+ and B- in this order (Table 2). 
No AB blood group was recorded. Of the 266 (O+), 
46(O-),  52(A+ ), 43(B+) and 3(B-) individuals blood 
samples examined, infection rates of 80.1%, 60.9%, 
63.5%, 65.1% and 66.7% were recorded 
respectively. The difference among blood group, 
with majority of O+ individuals (80.1%) infected 
was significant (χ2cal = 13.99, χ2tab = 9.48, df =4, p< 
0.05). Excluding O+ (the very high infected donors) 
the difference in infection in other observed blood 
groups (A+, O-, B+ and B-) was not significant (χ2cal = 
1.07, χ2tab = 7.815, df =3, p> 0.05). 
Infection was also recorded according to occupation 
(Table 3). Highest infection rate was seen among 
traders. However, infection rate seen among the 
different occupational groups was not significant 
(χ2cal = 4.68, χ2tab = 9.48, df =4, p> 0.05). 
 
DISCUSSION 
The high rate of positivity for malaria parasites in 
the blood of donors in this study is alarming. This 
strongly suggests a serious risk of transfusion-
transmitted malaria in the south-eastern Nigeria. 
Other similar studies in Nigeria with high malaria 
prevalence among blood donors abound 
(Ibhanesebho et al., 1996; Okocha et al., 2005; 
Uneke et al., 2006). In Onitsha, climate and 
vegetation are consistent with tropical rainforest. 
Tthe seasonal rainfall is higher and longer which 
gives rise to much surface water to support the 
breeding of vectors. The recorded high rate may be 
due to this. The period of study which is the rainy 
season also may have contributed to the high 
infection rate.  High rate of malaria transmission 
during rainy season has been reported (Uneke et al., 
2006). The number of parasites recorded in thick 
films (+, ++) does not indicate severe infection but 
then preservation of blood at 4oC does not destroy 
the parasites and one to two parasites per micro-
litre of blood which are undetected on thick or thin 
blood films are sufficient to transmit the illness 
(Umeanaeto et al., 2006). This is a major challenge 
to the problem of clinical and transfusion services 
all over the world. 
 
Majority of blood donors who are mostly males are 
commercial donors and they fall within the age 
range of 25-29 years. Transfusion malaria was 
described as particularly common in countries 
where blood donation has become a commercial 
transaction and where the blood donors come from 
less affluent social classes (Bruce-Chwatt, 1982; 
Adewuji, 2001). This feature is recorded in this 
study, as 88.8% of blood donors donated for money. 
This has become a dominant trait in the sub-
Saharan Africa including Nigeria, where majority of 
blood donors (commercial donors) are low income 
earners and live in places where vector 
transmission of malaria is high. The reason for the 
low number of female blood donors could be 
because females are culturally inhibited as far as 
commercial blood donation is concerned. 
Additionally, physiological changes such as 
menstruation, pregnancy, lactation and iron 
deficiency anaemia often hinder women from 
donating blood.  
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Nevertheless, only persons who were confirmed fit 
were involved in the study (see study population 
under materials and methods). Although the 
differences in infection among some blood groups 
was not significant, findings also showed that 
people with blood group O+ are significantly 
susceptible to malaria infection. Some reports 
however vary with this (Facer and Brown, 1979; 
Martin et al., 1979; Montoya et al., 1994). A 
suggestion to researchers in this field is therefore 
made. However, the high infection rates observed 
among all blood groups and their rhesus factor 
suggest that they are all susceptible to malaria.  In 
fact, there is evidence that the ABO histo-blood 
group is not correlated to the incidence of malaria 
(Fisher and Boone, 1998), but it has been linked as 
a co-receptor in parasite and vascular 
cytoadherence, with higher rosette rates among 
non-group O compared to group O erythrocytes 
(Cserti and Dzik , 2007). 
 
All occupational groups are also susceptible to 
malaria infection whether educated or not, as there 
was no significant difference recorded among them 
in this work. This shows that the disease is actually 
endemic and is a problem in this area. 
Asymptomatic carriers are generally the source of 
transfusion-transmitted malaria. Since apparently 
healthy individuals are selected for blood donation, 
density of parasites is usually very low, and may be 
easily missed (Kaur and Basu, 2005). In Sub-
Saharan Africa where malaria is hyper-endemic 
(Uneke et al., 2006), this can pose a serious health 
hazard to blood recipients. 
 
In as much as blood transfusion is required in 
severe anaemia due to malaria and other illnesses, 
safe blood transfusion should be guaranteed. This is 
because post-transfusional malaria may not only 
compound the already deplorable health condition 
of the recipients, but may also be fatal (Kitchen and 
Chiodini, 2006). Thus the need for effective donor 
selection guidelines cannot be overstated. In USA, 
approximately 150,000 donors are differed each 
year due to a perceived risk of malaria exposure. 
Contrarily, in Nigeria, especially south eastern 
Nigeria, such may not be feasible because almost 
every donor may be excluded due to malaria 
endemicity in the area. Due to paucity of blood 
donors in Nigeria, donor deferral cannot also be 
practiced. Commercial donors predominate in 
Nigeria and screening for malaria parasites is 
neither routinely done in Nigerian blood bank nor 
stipulated in the current National Blood 
Transfusion Guidelines (Federal Ministry of Health, 
1991; Umeanaeto et al., 2006). This may be because 
transmission of malaria through blood transfusion 
is generally not regarded as a serious problem as 
the area is holoendemic for malaria. 
 
It is therefore recommended that all blood pints be 
screened very carefully for malaria parasites and 
blood packs marked negative or positive as the case 
may be.  In case a patient is transfused with a 
malaria positive blood, the patient can be given a 
curative regimen of antimalarials, especially when 
the patient falls into the malaria vulnerable group 
(children, pregnant women, immigrants from 
outside malarious regions). Since most commercial 
donors are from low income groups, they should be 
freely given long lasting insecticide treated bed nets 
and fabrics (door and window blinds). They should 
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